Sejong Pharmatech Co., Ltd.
USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B30B (Presses IN General).
The verdict
According to USPTO PatentsView, Sejong ranks #42,875 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 4 technology areas.
- #42,875
- of 49,997 US assignees by volume
- 4th percentile
- by Innovation Score (16.8/100)
- 5.0
- avg claims per patent
- -50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R42875 · Foreign Corporation #42,875 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #42,875/49,997
- PHOTO-FINISH Seek XR
- CPC-NARROW B30B · 4 areas
- INNOV-LOW 16.8/100
- CLAIMS-SPARSE 5.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Seek XR, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Sejong’s 16.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Sejong
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Sejong Pharmatech · this assignee 17
Sejong Pharmatech · this assignee
17 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Sejong's Innovation Score is 16.8/100 (4th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Sejong?
Each dot is one of Sejong’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sejong’s own 5.0 claims/patent is at or below the 10.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Sejong's grants concentrate
Sejong Pharmatech Co., Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 50% of grants classified under B30B (Presses IN General). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, Sejong sits between Seek XR, Inc. and Sellars Absorbent Materials, Inc..
Who files at Sejong's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Seek XR
Seek XR, Inc.
6 patents
- SEE—Soluções Ener…
SEE—Soluções, Energia e Meio Ambiente Ltda.
6 patents
- Segton Advanced T…
Segton Advanced Technology
6 patents
- Seiko Clock
Seiko Clock Inc.
6 patents
- Sejong University…
Sejong University Industry Academy Cooperation Foundation
6 patents
- Selc Ireland
Selc Ireland Ltd
6 patents
- Select Star
Select Star, Inc.
6 patents
- Sellars Absorbent…
Sellars Absorbent Materials, Inc.
6 patents
- Sejong Pharmatech ◀
Sejong Pharmatech Co., Ltd.
6 patents
What this shows Sejong holds 6 patents at rank #42,783, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Sejong
By rank, the assignees closest to #42,783 in granted patent volume.
- Seek XR, Inc. #42,779 · 6 patents
- SEE—Soluções, Energia e Meio Ambiente Ltda. #42,780 · 6 patents
- Segton Advanced Technology #42,781 · 6 patents
- Seiko Clock Inc. #42,782 · 6 patents
- Sejong University Industry Academy Cooperation Foundation #42,784 · 6 patents
- Selc Ireland Ltd #42,785 · 6 patents
- Select Star, Inc. #42,786 · 6 patents
- Sellars Absorbent Materials, Inc. #42,787 · 6 patents
Leaders in B30B (Presses IN General)
Other assignees with the most granted patents in Sejong's primary technology class.
Sejong's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
17 4th percentile higher than 4% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2016 | 2 | 33.3% |
| 2019 | 1 | 16.7% |
| 2020 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
Which technologies does Sejong Pharmatech Co., Ltd. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Sejong Pharmatech Co., Ltd.'s patent record in context - here's where to go next.
- Sejong Pharmatech Co., Ltd.'s lead technology class is B30B (Presses IN General), 50% of its portfolio - see every assignee active in that class. Explore B30B
- Ranked #42,875 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Sejong Pharmatech Co., Ltd. against Seek XR, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 16.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.